Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers ...

The Prevent Cancer Foundation® is pleased to announce new funding for ten scientists who are exploring innovative approaches ...

Fanconi anemia (FA) is a rare genetic disorder characterized by defective DNA repair, leading to hematopoietic stem cell (HSC) dysfunction and bone marrow failure. Replication stress, which ...

Noticing any new changes to your skin, especially if a new growth pops up, only naturally sets off a series of internal alarm bells: Is that a mole, a wart, a melanoma? If that little bump on your ...

It’s winter in the Northern Hemisphere, and for many people that means having the spotlight on your body’s largest organ—skin. In cold climates the skin can become substantially drier ...

Medically reviewed by Soma Mandal, MD Petechiae are tiny red, purple, or brown spots on your skin, inside of your mouth, or ...

Feb. 3, 2025 — Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the ...

It's officially that time of the year: our skin is itchy, scaly, and more closely resembles a lizard than a dewy, glazed donut. You likely have a dozen barrier-repairing lip balms and thick hand ...

Helen Jackson's toddler, misdiagnosed with flu, was later found to have acute lymphoblastic leukemia after her condition worsened. Gracie, 2, underwent immediate treatment, including chemotherapy ...

Your skin is your body’s largest organ. It keeps you protected, helps you feel your environment, and keeps the rest of your body protected. Imagine how difficult life would be without skin that ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

Patients in the EU with Fanconi anaemia (FA) could soon have the first gene therapy option for the disorder, as the EMA starts a review of Rocket Pharma’s RP-L102 candidate. FA is an inherited ...